Abbott Labs’ Dividend Strength Is Top Notch (NYSE:ABT)

Sundry Photography By The Valuentum Team Dividend Aristocrat Abbott Laboratories (NYSE:ABT) is one of our favorite healthcare names, with a long storied history dating all the way back to its incorporation in 1900. We’re huge fans of its product line-up that ranges from gastroenterology and women’s health products, laboratory systems, and diagnostics flow testing products to infant formula including the brand Similac and medical devices for the heart and beyond. Despite its fantastic portfolio, Abbott still remains acquisitive as it seeks to continue to diversify its product portfolio across its four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.